Shionogi & Co., Ltd. engages in the research, development, manufacture, and distribution of pharmaceuticals, diagnostic reagents, and medical devices in Japan. It offers Fetroja, a multidrug-resistant for gram-negative bacterial infection treatment; Cabenuva and Apretude an anti-HIV and HIV prophylactic drug; Xocova an oral COVID-19 treatment drug; Finibax a carbapenem antibiotic; Xofluza, an influenza antiviral drug; and Tivicay, an anti-HIV drug. It also develops S-872600 an influenza nasal va...
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Phone: 81 6 6202 2161
Fax: 81 6 6229 9596
Address:
1-8, Doshomachi 3-chome, Chuo-ku, Osaka, Japan
